Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pfeiffer

Neurology

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Neurology|January 1, 1992
Optimization of levodopa therapyR Pfeiffer
Neurology|December 1, 1977
Experiences with a new ergoline (CF 25-397) in parkinsonismP F Teychenne, R Pfeiffer, S M Bern, et al.
Neurology|June 11, 2003
Longitudinal outcome of Parkinson's disease patients with psychosisS A Factor, P J Feustel, J H Friedman, et al.
Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.
Neurology|January 6, 2011
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD studyR N Alcalay, A Siderowf, R Ottman, et al.
Neurology|March 24, 2012
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD studyR N Alcalay, E Caccappolo, H Mejia-Santana, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Neurology|January 1, 1992
Optimization of levodopa therapyR Pfeiffer
Neurology|December 1, 1977
Experiences with a new ergoline (CF 25-397) in parkinsonismP F Teychenne, R Pfeiffer, S M Bern, et al.
Neurology|June 11, 2003
Longitudinal outcome of Parkinson's disease patients with psychosisS A Factor, P J Feustel, J H Friedman, et al.
Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.
Neurology|January 6, 2011
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD studyR N Alcalay, A Siderowf, R Ottman, et al.
Neurology|March 24, 2012
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD studyR N Alcalay, E Caccappolo, H Mejia-Santana, et al.
Pageof 1